[1] |
Clinical Laboratory Society of Chinese Association for Rehabilitation Medicine , Molecular Diagnostics Society of Shanghai Medical Association , Tumor Immunology Branch of Shanghai Society for Immunology , Yueyang Hospital of Integrated Traditional Chinese and Western Medicine of Shanghai University of Traditional Chinese Medicine , Shanghai Center for Clinical Laboratory, Clinical Laboratory Society of Chinese Association of Integrative Medicine , Clinical Laboratory Society of Shanghai Anticancer Association , Tumor Markers Society of Shanghai Anticancer Association .
Expert consensus on the clinical application of AFP,AFP-L3% and DCP using GALAD and GALAD-like models in hepatocellular carcinoma
[J]. Laboratory Medicine, 2023, 38(7): 607-623.
|
[2] |
CHEN Wenju, ZHOU Yong, XU Jiajia, WANG Pan.
Role of serum exosomal miR-23b-3p and miR-4429 in patients with hepatocellular carcinoma
[J]. Laboratory Medicine, 2023, 38(7): 624-628.
|
[3] |
YANG Yanmin, PENG MengLe, LIAN Wenping.
MDSC percentage and the expressions of RORα mRNA,IL-17E mRNA and FOXP3 mRNA in rectal cancer patients
[J]. Laboratory Medicine, 2023, 38(1): 23-27.
|
[4] |
HE Yaya, CHEN Shanshan, LI Yongsheng, LIU Juan.
Expressions of sLAIR-1 and LAIR-1 mRNA in AS patients and their relationship with disease activity
[J]. Laboratory Medicine, 2022, 37(10): 915-920.
|
[5] |
MENG Jun, WANG Junqing, FEI Xiaochun, GU Zhidong.
Establishment and validation of a plasma exosome-derived circular RNA model for HCC diagnosis
[J]. Laboratory Medicine, 2022, 37(1): 1-10.
|
[6] |
TONG Lin, HUANG Chenjun, GAO Zhiyuan, ZHOU Jun, FANG Meng, XIAO Xiao, HE Yutong, HONG Song, XU Minfan, ZHU Feifei, GAO Chunfang.
Study on the judgment model of preoperative microvascular invasion in HCC based on common clinical determination items
[J]. Laboratory Medicine, 2020, 35(8): 741-748.
|
[7] |
JIN Fangfang, JIN Zizheng, LIU Ning, LOU Jinli.
Changes of CD3bright T lymphocytes in patients with hepatocellular carcinoma before and after recurrence
[J]. Laboratory Medicine, 2020, 35(3): 209-213.
|
[8] |
BIE Lihan, FANG Meng, FENG Huijuan, LU Zhicheng, GAO Chunfang.
Role of sialylated haptoglobin for the auxiliary diagnosis of hepatitis B-related hepatocellular carcinoma
[J]. Laboratory Medicine, 2020, 35(11): 1147-1152.
|
[9] |
GUAN Wenqian, GAO Zhiyuan, FENG Huijuan, HONG Song, HE Yutong, HE Lu, GAO Chunfang.
Establishment of Lectin-ELISA for the detection of multi-antennary AAG and its preliminary application
[J]. Laboratory Medicine, 2020, 35(11): 1177-1185.
|
[10] |
CHEN Xu, FENG Juan, HU Xiaobo, WANG Changfu.
Research progress of pseudouridine as a biomarker of kidney disease and cancer
[J]. Laboratory Medicine, 2019, 34(9): 864-867.
|
[11] |
MING Xinliang, LIU Xuefang, ZHU Man, TU Jiancheng.
Clinical application progress of circulating free nucleic acid in the diagnosis and treatment of hepatocellular carcinoma
[J]. Laboratory Medicine, 2019, 34(7): 667-671.
|
[12] |
FANG Zixiang, ZHANG Xiao, CHEN Yan, WU Qi, ZHU Guoqing, LIU Ya, WANG Jiayi, SUN Fenyong, YU Lei.
Role of TFCP2/YAP transcriptional complex co-regulated protein CPE for the diagnosis of hepatocellular carcinoma
[J]. Laboratory Medicine, 2019, 34(2): 103-109.
|
[13] |
TANG Jie, YANG Yuwei, WANG Kun, YU Jing.
Establishment the reference interval of adult protein-induced vitamin K absence/antagonist Ⅱ by chemiluminescent microparticle immunoassay
[J]. Laboratory Medicine, 2019, 34(12): 1072-1076.
|
[14] |
CAO Minlu, SHEN Minna, ZHOU Yan, WANG Beili, ZHANG Chunyan, PAN Baishen, GUO Wei.
Performance comparison of the detection of circulating tumor cells in hepatocellular carcinoma patients by qRT-PCR platform and CellSearch system
[J]. Laboratory Medicine, 2019, 34(10): 927-931.
|
[15] |
SHANG Lu, ZHAO Xiao, CHEN Yan, WU Qi, ZHU Guoqing, LIU Ya, WANG Jiayi, SUN Fenyong, ZHANG Lei.
Hippo/YAP signaling pathway regulation protein ACAN as a new serum tumor marker for hepatocellular carcinoma
[J]. Laboratory Medicine, 2019, 34(1): 60-66.
|